We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$773M
AUM Growth
-$71.9M
Cap. Flow
-$78.8M
Cap. Flow %
-10.19%
Top 10 Hldgs %
77.44%
Holding
144
New
42
Increased
11
Reduced
17
Closed
69

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$11.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$10.8M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10.8M
4
ARES icon
Ares Management
ARES
+$10.2M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$10.2M

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.4M
2
SN icon
SharkNinja
SN
+$14.8M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$11.2M
4
ODD icon
ODDITY Tech
ODD
+$8.91M
5
GE icon
GE Aerospace
GE
+$8.43M

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 4.5%
3 Industrials 3.66%
4 Financials 3.35%
5 Consumer Discretionary 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMNM icon
101
Immunome
IMNM
$2.83B
– –
-132,500
Closed -$3.27M
IMVT icon
102
Immunovant
IMVT
$8.25B
– –
-100,000
Closed -$3.23M
KDP icon
103
Keurig Dr Pepper
KDP
$40.8B
– –
-10,000
Closed -$307K
KNTK icon
104
Kinetik
KNTK
$7.98B
– –
-125,000
Closed -$4.98M
KRRO icon
105
Korro Bio
KRRO
$195M
– –
-55,364
Closed -$4.98M
KSPI icon
106
Kaspi.kz JSC
KSPI
$17.2B
– –
-87,000
Closed -$11.2M
MIST icon
107
Milestone Pharmaceuticals
MIST
$152M
– –
-500,000
Closed -$895K
MLNK
108
DELISTED
MeridianLink
MLNK
– –
-80,000
Closed -$1.5M
MRSN
109
DELISTED
Mersana Therapeutics
MRSN
– –
-12,400
Closed -$1.39M
MTDR icon
110
Matador Resources
MTDR
$6.09B
– –
-60,000
Closed -$4.01M
NAMS icon
111
NewAmsterdam Pharma
NAMS
$3.34B
– –
-170,000
Closed -$4.02M
NAMSW icon
112
NewAmsterdam Pharma Warrant
NAMSW
$78.2M
– –
-31,189
Closed -$344K
NCDL icon
113
Nuveen Churchill Direct Lending
NCDL
$633M
– –
-95,963
Closed -$1.73M
NDAQ icon
114
Nasdaq
NDAQ
$52.9B
– –
-105,000
Closed -$6.63M
NSSC icon
115
Napco Security Technologies
NSSC
$1.48B
– –
-90,000
Closed -$3.61M
ODD icon
116
ODDITY Tech
ODD
$651M
– –
-205,000
Closed -$8.91M
OLMA icon
117
Olema Pharmaceuticals
OLMA
$1.05B
– –
-135,000
Closed -$1.53M
PCVX icon
118
Vaxcyte
PCVX
$8.64B
– –
-100,000
Closed -$6.83M
PEPG icon
119
PepGen
PEPG
$197M
– –
-85,886
Closed -$1.26M
PGY icon
120
Pagaya Technologies
PGY
$1.78B
– –
-247,732
Closed -$2.5M
PRAX icon
121
Praxis Precision Medicines
PRAX
$10.1B
– –
-20,000
Closed -$1.22M
PRCH icon
122
Porch Group
PRCH
$1.8B
– –
-350,000
Closed -$1.51M
PYXS icon
123
Pyxis Oncology
PYXS
$236M
– –
-442,500
Closed -$1.89M
RDNT icon
124
RadNet
RDNT
$5.69B
– –
-100,000
Closed -$4.87M
RWAY icon
125
Runway Growth Finance
RWAY
$287M
– –
-70,000
Closed -$848K
2 3 4
5
6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monashee Investment Management held 144 positions worth $773M, down 8.5% from $845M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Monashee Investment Management withdrew a net $78.8M in Q2 2024, closing 69 positions and reducing 17 holdings. Its most notable exit was AB InBev, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Monashee Investment Management opened a new position in Ares Management worth $10M.

  • Monashee Investment Management's largest Q2 2024 buy was Ares Management: 75,000 shares worth $10M.
  • Monashee Investment Management added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $11.8M increase.
  • Monashee Investment Management's biggest Q2 2024 reduction was REV Group, cutting an estimated $4.76M.
  • Monashee Investment Management fully exited AB InBev in Q2 2024, selling an estimated $16.4M.
  • Monashee Investment Management's ten largest holdings make up 77% of its $773M portfolio in Q2 2024.
  • Monashee Investment Management opened 42 new positions and closed 69 in Q2 2024.
  • Monashee Investment Management's portfolio value fell 8.5% quarter-over-quarter to $773M.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.